These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19264587)

  • 41. Efficacy and prognosis of a short course of prednisolone therapy for pediatric epilepsy.
    You SJ; Jung DE; Kim HD; Lee HS; Kang HC
    Eur J Paediatr Neurol; 2008 Jul; 12(4):314-20. PubMed ID: 17951084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levetiracetam in the treatment of Lennox-Gastaut syndrome.
    De Los Reyes EC; Sharp GB; Williams JP; Hale SE
    Pediatr Neurol; 2004 Apr; 30(4):254-6. PubMed ID: 15087103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and tolerability of antiepileptic drugs in an Omani epileptic population.
    Hanssens Y; Al-Asmi A; Al-Busaidi I; Deleu D
    Clin Neurol Neurosurg; 2006 Sep; 108(6):532-8. PubMed ID: 16169660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Could Adult European Pharmacoresistant Epilepsy Patients Be Treated With Higher Doses of Zonisamide?
    Miro J; Jaraba S; Juvany R; Santurino M; Cobo S; Falip M
    Clin Neuropharmacol; 2016; 39(3):121-4. PubMed ID: 26818046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term retention rate of zonisamide in patients with epilepsy: an observational study.
    Kim DW; Choi K; Moon HS; Oh J
    Clin Neuropharmacol; 2014; 37(5):133-5. PubMed ID: 25229169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levetiracetam in the treatment of idiopathic generalized epilepsies.
    Grünewald R
    Epilepsia; 2005; 46 Suppl 9():154-60. PubMed ID: 16302890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Broad-spectrum efficacy of zonisamide at 12 months in children with intractable epilepsy.
    Mandelbaum DE; Bunch M; Kugler SL; Venkatasubramanian A; Wollack JB
    J Child Neurol; 2005 Jul; 20(7):594-7. PubMed ID: 16159527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuromodulation of the centromedian thalamic nuclei in the treatment of generalized seizures and the improvement of the quality of life in patients with Lennox-Gastaut syndrome.
    Velasco AL; Velasco F; Jiménez F; Velasco M; Castro G; Carrillo-Ruiz JD; Fanghänel G; Boleaga B
    Epilepsia; 2006 Jul; 47(7):1203-12. PubMed ID: 16886984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential efficacy of zonisamide in refractory juvenile myoclonic epilepsy: retrospective evidence from an Irish compassionate-use case series.
    O'Rourke D; Flynn C; White M; Doherty C; Delanty N
    Ir Med J; 2007 Apr; 100(4):431-3. PubMed ID: 17566478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness and tolerability of zonisamide in children with epilepsy: a retrospective review.
    Tan HJ; Martland TR; Appleton RE; Kneen R
    Seizure; 2010 Jan; 19(1):31-5. PubMed ID: 19942456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.
    Miró J; Aiguabella M; Veciana M; Juvany R; Santurino M; Leiva E; Salas-Puig J; Falip M
    Acta Neurol Scand; 2014 May; 129(5):e20-3. PubMed ID: 24372179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
    Verrotti A; Cerminara C; Coppola G; Franzoni E; Parisi P; Iannetti P; Aloisi P; Tozzi E; Cusmai R; Vigevano F; Chiarelli F; Curatolo P
    Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation.
    Nei M; O'Connor M; Liporace J; Sperling MR
    Epilepsia; 2006 Jan; 47(1):115-22. PubMed ID: 16417539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seizure aggravation in idiopathic generalized epilepsies.
    Chaves J; Sander JW
    Epilepsia; 2005; 46 Suppl 9():133-9. PubMed ID: 16302887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy, tolerability, and retention rates of zonisamide in older adult patients with focal-onset epilepsy: Experiences from two tertiary epilepsy centers.
    Doğan EA; Genç E; Genç BO; Erdoğan Ç
    Epilepsy Behav; 2017 Nov; 76():19-23. PubMed ID: 28927711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center.
    Kim HL; Aldridge J; Rho JM
    J Child Neurol; 2005 Mar; 20(3):212-9. PubMed ID: 15832611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs.
    Bergey GK
    Epilepsia; 2005; 46 Suppl 9():161-8. PubMed ID: 16302891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.
    Zachry WM; Doan QD; Clewell JD; Smith BJ
    Epilepsia; 2009 Mar; 50(3):493-500. PubMed ID: 18616554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Idiopathic generalized epilepsies: a follow-up study in a single-center.
    Kharazmi E; Peltola M; Fallah M; Keränen T; Peltola J
    Acta Neurol Scand; 2010 Sep; 122(3):196-201. PubMed ID: 19919644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Zonisamide as add-on treatment for focal epilepsies. An outcome analysis of 74 patients].
    Wellmer S; Wellmer J; Bauer J
    Nervenarzt; 2008 Dec; 79(12):1416, 1418-23. PubMed ID: 18633587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.